Time in range in patients with type 2 diabetes who are long-term users of d-Nav®, an artificial intelligence-driven technology for autonomous titration of insulin dosing

Diabetes Obes Metab. 2023 Dec;25(12):3845-3848. doi: 10.1111/dom.15280. Epub 2023 Sep 18.
No abstract available

Keywords: artificial intelligence; continuous glucose monitor; insulin therapy; time in range; type 2 diabetes mellitus.

Publication types

  • Letter

Grants and funding